Vor Biopharma – pharmaceutical daily

October 1, 2019 Off

Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced…

August 7, 2019 Off

Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer

By BusinessWire

Company expands into integrated labs and offices in global biotech hub of Kendall Square CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vor Biopharma, an oncology…

May 29, 2019 Off

Vor Biopharma says in journal that CD33-deficient HSCs can successfully engraft into the bone marrow of their host

By BusinessWire

Preclinical study supports Vor’s approach for empowering targeted
immunotherapies through hematopoietic stem cell editing

Paper co-authored by Vor co-founder Dr. Siddhartha Mukherjee